Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Doubleblind, Vehicle-controlled, Parallel-group Trial to Assess the Efficacy, Safety and Tolerability of P-3073 for Topical Treatment of Nail Psoriasis

NCT03079973 is registered in ClinicalTrials.gov with Polichem S.A. as lead sponsor.

NCT NCT03079973
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03079973 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Doubleblind, Vehicle-controlled, Parallel-group Trial to Assess the Efficacy, Safety and Tolerability of P-3073 for Topical Treatment of Nail Psoriasis
Lead sponsor
Polichem S.A.
Phase
Phase 3
Overall status
Withdrawn
Start date
May 15, 2017
Completion date
July 31, 2018
Enrollment
0 (actual)
Sites
58

Conditions

As the registry lists them; a condition with its own page is linked.

nail psoriasis